ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
North Terrace House,
19 North Terrace,
Hackney, SA, 5069
1300 128 339
Closed over Christmas
(reopened 1 February 2017)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Medical Edge: Fibromyalgia study
Friday 27 December 2013
Medical Edge: Fibromyalgia Study
CINCINNATI (Liz Bonis) -- It's not uncommon to say the kind of cold weather we've had lately can chill you to the bone.
But when that bone chilling cold leads to chronic aches and pains, that's how many people describe the chilling affect of fibromyalgia.
Dr. Lesley Arnold says, "Fibromyalgia is a very common chronic pain condition that predominantly effects women but it can occur in both men and women. It's characterized by widespread pain all over the body."
So doctor Lesley Arnold is one of a handful of researchers in a nationwide study trying to find out what's happening in the brain and the body when people experience additional symptoms from this kind of pain.
"So we are assessing sleep, pain, energy depression anxiety, as well as concentration."
Arnold's team is testing an investigatory medication to potentially ease these fibromyalgia symptoms in a clinical trial still looking for patients.
The trial is open to both men and women ages 18 to 65. It may be especially helpful if you've tried other medications that don't work. This one appears to work differently than a few others on the market.
"We think fibromyalgia has to do with some disordered pain processing system in the central nervous system, and there are certain neurotransmitters that we think are involved in fibromyalgia. And this new medication can improve the behavior or action of these neurotransmitters, which can help then relieve pain."
Initial phases compare the investigational medication to a placebo or sugar pill. But if it works the next phase would allow those in the trial to continue its use.
If you'd like more information on this study you can call 513-558-6612. If you qualify for the study you are paid for time and travel.
The above originally appeared here.
blog comments powered by Disqus